Atai Life Sciences N.V.

XTRA:9VC Stock Report

Market Cap: €191.4m

Atai Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

XTRA:9VC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 May 24Sell€267,262Florian BrandIndividual151,303€1.77
02 Apr 24Sell€61,503Sahil KirpekarIndividual35,801€1.72
02 Apr 24Sell€105,892Srinivas RaoIndividual61,640€1.72
02 Apr 24Sell€47,088Anne JohnsonIndividual27,410€1.72

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 9VC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,285,8213.15%
Institutions25,278,29015.1%
VC/PE Firms33,885,99920.2%
General Public103,352,28661.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 37.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.2%
Apeiron Investment Group
33,885,999€38.6m0%56.88%
6.43%
Galaxy Group Investments LLC
10,796,736€12.3m0%0.36%
2.48%
Christian Angermayer
4,166,502€4.8m0%no data
1.35%
Walleye Capital LLC
2,264,912€2.6m-18%0.02%
1.1%
Morgan Stanley Investment Management Inc.
1,849,959€2.1m4.18%no data
1.07%
Presight Capital
1,799,302€2.1m0%21.14%
0.76%
BlackRock, Inc.
1,271,021€1.4m-2.75%no data
0.71%
Morgan Stanley, Investment Banking and Brokerage Investments
1,184,101€1.4m26%no data
0.43%
Brown University Endowment
718,500€819.4k0%0.32%
0.32%
Woodline Partners LP
535,047€610.2k0%0.01%
0.31%
Michael B. Auerbach
524,308€598.0k0%no data
0.26%
Millennium Management LLC
441,727€503.8k-31.9%no data
0.26%
Kieger AG
438,300€499.9k0%0.16%
0.24%
The Vanguard Group, Inc.
407,684€465.0k-0.92%no data
0.24%
Two Sigma Investments, LP
407,183€464.4k-43.2%no data
0.21%
Fiduciary Trust Company International
356,357€406.4k0%no data
0.2%
Florian Brand
331,030€377.5k0%no data
0.19%
AllianceBernstein L.P.
316,732€361.2k16.9%no data
0.15%
Bank of America Corporation, Asset Management Arm
259,490€295.9k116%no data
0.15%
Barclays PLC Private Banking & Investment Banking Investment
246,446€281.1k0.34%no data
0.13%
Kairos Investment Management, Ltd.
212,696€242.6k0%0.08%
0.1%
Hyperion Capital Advisors LP
168,416€192.1k0%0.09%
0.1%
AdvisorShares Investments, LLC
167,831€191.4k-16.4%0.03%
0.097%
Goldman Sachs Group, Investment Banking and Securities Investments
162,765€185.6k-17.4%no data
0.07%
Srinivas Rao
116,860€133.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:18
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Atai Life Sciences N.V. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Leonildo DelgadoBaader Helvea Equity Research
Sumant Satchidanand KulkarniCanaccord Genuity
Charles DuncanCantor Fitzgerald & Co.